Clinical Characteristics and Use of Traditional Chinese Medicine Therapy in 222 Malignant Tumor Cases with COVID-19： A Retrospective Study

WANG Yingtian; SUN Hong; LI Man; SONG Na; GOU Jiao; LUO Wenfang; LIU Jun; MA Rong; WANG Wei; LI Zhandong; MENG Bo; YAO Xiaoyan

doi:10.13288/j.11-2166/r.2024.07.010

您当前的位置：

首页 >

文章列表页 >

Clinical Characteristics and Use of Traditional Chinese Medicine Therapy in 222 Malignant Tumor Cases with COVID-19： A Retrospective Study

更新时间：2024-04-09

- Clinical Characteristics and Use of Traditional Chinese Medicine Therapy in 222 Malignant Tumor Cases with COVID-19： A Retrospective Study
- Journal of Traditional Chinese Medicine Vol. 65, Issue 7, Pages: 716-721(2024)
- 作者机构：
  
  1.北京大学肿瘤医院暨北京市肿瘤防治研究所，北京市海淀区阜成路52号，100142
  2.湖北省肿瘤医院
  3.重庆市中医院
  4.陕西省中医医院
  5.湖南南华大学附属第一医院
  6.南通大学附属南京江北医院
  7.内蒙古自治区中医医院
  8.中国中医科学院广安门医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2024.07.010
  CLC：
- Received：05 June 2023，
  
  Revised：2023-11-30，
  
  Published：02 April 2024
- 稿件说明：
移动端阅览
王应天,孙红,李嫚等.222例感染新型冠状病毒的恶性肿瘤患者临床特征及中医药应用情况回顾性研究[J].中医杂志,2024,65(07):716-721.

WANG Yingtian,SUN Hong,LI Man,et al.Clinical Characteristics and Use of Traditional Chinese Medicine Therapy in 222 Malignant Tumor Cases with COVID-19： A Retrospective Study[J].Journal of Traditional Chinese Medicine,2024,65(07):716-721.
王应天,孙红,李嫚等.222例感染新型冠状病毒的恶性肿瘤患者临床特征及中医药应用情况回顾性研究[J].中医杂志,2024,65(07):716-721. DOI： 10.13288/j.11-2166/r.2024.07.010.

WANG Yingtian,SUN Hong,LI Man,et al.Clinical Characteristics and Use of Traditional Chinese Medicine Therapy in 222 Malignant Tumor Cases with COVID-19： A Retrospective Study[J].Journal of Traditional Chinese Medicine,2024,65(07):716-721. DOI： 10.13288/j.11-2166/r.2024.07.010.

摘要

目的

研究感染新型冠状病毒（新冠病毒）的恶性肿瘤患者临床特征及中医药应用情况，为疫病背景下恶性肿瘤患者中医药防治策略及诊疗重点提供参考。

方法

回顾性采集2023年1月1—20日全国7家研究中心接诊的225例感染新冠病毒的恶性肿瘤患者病历资料，收集患者感染后主要症状及持续时间、核酸转阴时间、中医药应用情况、恢复抗肿瘤治疗后不良反应变化情况。

结果

共纳入222例患者病历资料进行分析，其中轻型205例，中型17例。临床报告频次较高的前4个症状依次为发热（165例次）、咳痰/干咳（99例次）、食欲下降（95例次）及乏力（85例次），其中40例次咳痰/干咳、37例次乏力、29例次食欲下降持续超过14天。核酸报告明确转阴时间的105例患者中位转阴时间为14天，其中肺癌较消化系统恶性肿瘤、有骨髓抑制较无骨髓抑制患者核酸转阴时间延长（

＜0.01）。在感染期间应用中成药治疗的患者占47.30%（105/222），中药汤剂占21.17%（47/222）；预防及康复阶段中医药应用比例分别为1.80%（4/222）、7.21%（16/222）。核酸转阴后恢复原方案抗肿瘤药物治疗的55例患者同步予以中医药防护治疗，观察到的不良反应包括消化道反应、骨髓抑制、神经毒性均为1~2级，随访期间无新增不良事件。

结论

部分感染新冠病毒的恶性肿瘤患者症状持续时间及核酸转阴时间延长，合理应用中医药治疗手段可促进患者康复，有助于感染后抗肿瘤治疗的顺利进行。

Abstract

Objective

To analyze the clinical characteristics and the use of traditional Chinese medicine （TCM） therapy in cancer patients with COVID-19， and to provide reference for making TCM prevention and treatment strategies and determining diagnosis and treatment priorities for patients with malignant tumors in the COVID-19 epidemic.

Methods

The medical records of 225 malignant tumor cases with COVID-19 who were admitted to 7 national research centers from January 1st to 20th， 2023 were retrospectively collected， and the main symptoms and duration after infection， nucleic acid negative conversion time， use of TCM therapy， and changes in adverse reactions after resuming anti-tumor treatment were analyzed.

Results

A total of 222 malignant tumor patients with COVID-19 were included in the analysis， involving 205 mild cases and 17 moderate cases. The top four most frequently reported clinical symptoms were fever （165 cases）， expectoration or dry cough （99 cases）， decreased appetite （95 cases） and fatigue （85 cases）， of which 40 expectoration or dry cough cases ， 37 fatigue cases and 29 decreased appetite cases lasted for more than 14 days. One hundred and five patients with nucleic acid detection report had a median negative conversion time of 14 days. The nucleic acid negative conversion time was significantly longer in patients with lung cancer compared to those with digestive system malignant tumors， and in those with myelosuppression than those without （

＜0.01）. During the infection period， 47.30% （105/222） of the patients used Chinese patent medicine， and 21.17% （47/222） were treated with herbal decoctions. The use of TCM in patients during the prevention and rehabilitation period， was 1.80%（4/222） and 7.21%（16/222）， respectively. Fifty-five patients resumed anti-tumor treatment after nucleic acid negative conversion， and received TCM simultaneously. Observed adverse reactions， including gastrointestinal reactions， bone marrow suppression， and neurotoxicity， were all grade 1 to 2， and no new adverse events occurred during follow-up.

Conclusion

Certain malignant tumor patients with COVID-19 had prolonged symptoms and nucleic acid negative conversion time Rational use of TCM can help to promote the rehabilitation of the patients and ensure the smooth process of anti-tumor treatment after infection.

关键词

Keywords

references

国家卫生健康委员会宣传司 . 国务院联防联控机制2022年3月19日新闻发布会文字实录［EB/OL］.（ 2022-03-19 ）［ 2023-04-02 ］. http：//www.nhc.gov.cn/ylyjs/pqt/202301/32de5b2ff9bf4eaa88e75bdf7223a65a.shtml http://www.nhc.gov.cn/ylyjs/pqt/202301/32de5b2ff9bf4eaa88e75bdf7223a65a.shtml .

TIAN J ， YUAN X ， XIAO J ， et al . Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan，China：a multicentre， retrospective，cohort study ［J］. Lancet Oncol ， 2020 ， 21 （ 7 ）： 893 - 903 .

GOSHEN-LAGO T ， WALDHORN I ， HOLLAND R ， et al . Serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer ［J］. JAMA Oncol ， 2021 ， 7 （ 10 ）： 1507 - 1513 .

VECCHIONE L ， STINTZING S ， PENTHEROUDAKIS G ， et al . ESMO management and treatment adapted recommendations in the COVID-19 era： colorectal cancer ［J］. ESMO Open ， 2020 ， 5 （ 3 ）： e000826 . doi： 10.1136/esmoopen-2020-000826 http://dx.doi.org/10.1136/esmoopen-2020-000826 .

中国抗癌协会肿瘤支持治疗专业委员会，中国抗癌协会肿瘤临床化疗专业委员会 . 新型冠状病毒肺炎疫情期间实体肿瘤患者防护和诊治管理相关问题中国专家共识（2022版）［J］. 中华肿瘤杂志， 2022 ， 44 （ 10 ）： 1083 - 1090 .

石远凯，孙燕 . 临床肿瘤内科手册［M］. 北京：人民卫生出版社， 2015 ： 267 - 699 .

中华人民共和国国家卫生健康委员会，国家中医药局综合司 . 新型冠状病毒感染诊疗方案（试行第十版）［J］. 中国合理用药探索， 2023 ， 20 （ 1 ）： 1 - 11 .

中国抗癌协会肿瘤营养专业委员会，中华医学会肠外肠内营养学分会 . 中国肿瘤营养治疗指南2020 ［M］. 北京：人民卫生出版社， 2020 ： 29 - 37 .

AMINMB ， EDGESB ， GREENEFL ， et al . AJCC Cancer Staging Manual . 8th ed ［M］. New York ： Springer ， 2017 ： 3 - 12 .

林洪生 . 恶性肿瘤中医诊疗指南［M］. 北京：人民卫生出版社， 2014 ： 36 - 79 .

National Cancer Institute . NCI Common Terminology Criteria for Adverse Events（CTCAE） v 5 . 0 ［EB/OL］.（ 2017-11-27 ）［ 2023-04-02 ］. https：//ctep. cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_ archive https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_archive .

ZHENG JP ， LING Y ， JIANG LS ， et al . Effects of Lianhuaqingwen capsules in adults with mild-to-moderate coronavirus disease 2019： an international， multicenter， double-blind， randomized controlled trial ［J］. Virol J ， 2023 ， 20 （ 1 ）： 277 .

HU K ， GUAN WJ ， BI Y ， et al . Efficacy and safety of Lianhuaqingwen capsules， a repurposed Chinese herb， in patients with coronavirus disease 2019： a multicenter， prospective， randomized controlled trial ［J］. Phytomedicine ， 2021 ， 85 ： 153242 . doi： 10.1016/j.phymed.2020.153242 http://dx.doi.org/10.1016/j.phymed.2020.153242 .

《中成药治疗优势病种临床应用指南》标准化项目组 . 中成药治疗癌因性疲乏临床应用指南（2020年）［J］. 中国中西医结合杂志， 2021 ， 41 （ 5 ）： 534 - 540 .

程艳野，李志刚 . 癌因性疲乏中西医治疗研究进展［J］. 中国中医药图书情报杂志， 2023 ， 47 （ 1 ）： 108 - 112 .

车文文，杨静雯，夏小军，等 . 针灸防治癌因性疲乏临床实践指南研究［J］. 世界中医药， 2021 ， 16 （ 10 ）： 1594 - 1598，1603 .

XU WX ， PIPER-VALLILLO AJ ， BINDAL P ， et al . Time to SARS-CoV-2 clearance among patients with cancer and COVID-19 ［J］. Cancer Med ， 2021 ， 10 （ 5 ）： 1545 - 1549 .

GRIVAS P ， KHAKI AR ， WISE-DRAPER TM ， et al . Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer： a report from the COVID-19 and Cancer Consortium ［J］. Ann Oncol ， 2021 ， 32 （ 6 ）： 787 - 800 .

DATTA SD ， TALWAR A ， LEE JT ， et al . A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection：illness beyond acute infection and public health implications ［J］. JAMA ， 2020 ， 324 （ 22 ）： 2251 - 2252 .

BHATRAJU PK ， GHASSEMIEH BJ ， NICHOLS M ， et al . COVID -19 in critically ill patients in the Seattle region-case series ［J］. N Engl J Med ， 2020 ， 382 （ 21 ）： 2012 - 2022 .

段璨，夏文广，郑婵娟，等 . 金花清感颗粒联合西医常规治疗方案治疗轻型新型冠状病毒肺炎的临床观察［J］. 中医杂志， 2020 ， 61 （ 17 ）： 1473 - 1477 .

张笑言，梁群，朱嘉敏，等 . 中医药治疗72例“德尔塔”毒株新型冠状病毒肺炎患者的回顾性研究［J］. 中华中医药学刊， 2022 ， 40 （ 11 ）： 28 - 32 .

郭凯凯，郭东霖，陈晓宇，等 . 新型冠状病毒下中晚期胃癌患者免疫力减退的中医外治［J］. 实用中医内科杂志， 2021 ， 35 （ 6 ）： 40 - 43 .

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Traditional Chinese Medicine Therapy on Immune Reconstitution in Children after Hematopoietic Stem Cell Transplantation：A Retrospective Real-World Study

Expert Consensus on the Clinical Application of Brain-Heart Simultaneous Treatment in Traditional Chinese Medicine

Advantages，Challenges，and Implementation Pathways of Natural Experiments in Evaluating the Efficacy of Traditional Chinese Medicine

Clinical Efficacy and Economic Evaluation of 1293 Non-Severe Adult Patients with Community-Acquired Pneumonia Treated by the Jiangsu Traditional Chinese Medicine Diagnosis and Treatment Protocol for Dominant Diseases：A Multicenter，Retrospective Real-World Cohort Study

Traditional Chinese Medicine Therapy for Active Ulcerative Colitis：A Multicenter Bidirectional Cohort Study

Related Author

HUANG Baoyi

YI Lichen

LI Yanwei

HUANG Ke

XU Hua

Project Group of the Expert Consensus on the Clinical Application of Brain-Heart Simultaneous Treatment in Traditional Chinese Medicine, China Association of Chinese Medicine

LIU Rihe

LIU Tingxiu

Related Institution

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Guangdong Clinical Research Academy of Chinese Medicine

Guangzhou University of Chinese Medicine

Children's Medical Center，SunYat-sen Memorial Hospital，SunYat-sen University

Center for Evidence-Based Medicine，Beijing University of Chinese Medicine

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰